Histone-lysine N-methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc-driven liver cancer.
Thng DKH, Hooi L, Toh CCM, Lim JJ, Rajagopalan D, Syariff IQC, Tan ZM, Rashid MBMA, Zhou L, Kow AWC, Bonney GK, Goh BKP, Kam JH, Jha S, Dan YY, Chow PKH, Toh TB, Chow EK.
Thng DKH, et al. Among authors: rashid mbma.
Mol Oncol. 2023 Nov;17(11):2275-2294. doi: 10.1002/1878-0261.13417. Epub 2023 Mar 29.
Mol Oncol. 2023.
PMID: 36896891
Free PMC article.